News（October 12 2019）Bevacizumab， A VEGF Human Monoclonal Antibodies，is going to start its Phase I clinical trial in one of the Best Phase I site, The First Affiliate Hospital of Bengfu Medical University.

It took only a little more than 4 weeks from site selection to the IEC approval. It is H&J speed!